Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Poxel Receives Approval to Extend TWYMEEG® Use for Diabetic Patients with Renal Impairment
Wednesday, April 09, 2025Poxel has announced that the Pharmaceuticals and Medical Devices Agency PMDA in Japan has approved an update to the package insert for TWYMEEGTWYMEEG has been available in Japan since September through a partnership between Poxel and Sumitomo Pharma
Avidity Biosciences Granted Orphan Drug Designation in Japan for Myotonic Dystrophy Type 1 Therapy
Wednesday, April 09, 2025Avidity Biosciences has received Orphan Drug designation in Japan from the Ministry of Health Labour and Welfare MHLW for its lead investigational treatment delpacibart etedesiran also known as deldesiran for myotonic dystrophy type DM
CAS and Cleveland Clinic Partner to Advance Research Using AI and Quantum Computing
Tuesday, April 08, 2025CAS has announced a strategic partnership with Cleveland Clinic The collaboration aims to combine the strengths of both organisations to support clinical research with a particular focus on brain health and healthy ageing
Engine Biosciences Enters into Partnership with EDDC to Develop New Precision Cancer Therapies
Tuesday, April 08, 2025Engine Biosciences has entered into a strategic partnership with the Experimental Drug Development Centre EDDC This collaboration aims to accelerate the development of new precisionbased cancer treatments
Ethris and Lonza Partner to Develop Room-Temperature mRNA Vaccines for Respiratory Diseases
Monday, April 07, 2025Ethris has joined forces with Lonza to develop roomtemperature stable spraydried mRNAbased vaccine formulations
ABL Bio Enters into Agreement with GSK to Develop Treatments for Neurodegenerative Diseases
Monday, April 07, 2025ABL Bio has entered into a global licensing agreement with GSK The deal grants GSK access to ABL Bios GrabodyB platform a technology designed to improve the delivery of treatments across the bloodbrain barrier BBB
Daiichi Sankyo and AstraZeneca’s ENHERTU® Approved in EU for HER2 Low Breast Cancer
Saturday, April 05, 2025Daiichi Sankyo and AstraZeneca have announced that the European Commission EC has approved ENHERTU trastuzumab deruxtecan for treating adult patients with unresectable or metastatic HERlow breast cancer who have received prior chemotherapy in the met...
Santen Secures NMPA Approval for Tapcom to Treat Open-Angle Glaucoma and Ocular Hypertension in China
Friday, April 04, 2025Santen Pharmaceutical has received approval from Chinas National Medical Products Administration NMPA for its Marketing Authorisation Application for Tapcom a preservativefree fixedcombination eye drop
Sangamo Therapeutics Enters into Agreement with Lilly Sign for Gene Therapy in Neurological Diseases
Friday, April 04, 2025Sangamo Therapeutics has entered into a licence agreement with Eli Lilly and Company Lilly to support the development of genomic medicines for central nervous system CNS disorders The agreement grants Lilly global exclusive rights to use Sangamos neu...
Novartis Secures FDA Approval for Vanrafia® to Treat Primary IgA Nephropathy
Thursday, April 03, 2025Novartis has received accelerated approval from the US Food and Drug Administration FDA for Vanrafia atrasentan a selective endothelin A ETA receptor antagonist for reducing proteinuria in adults with primary immunoglobulin A nephropathy IgAN who are...
